Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rankning i aktier #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Aktiekurs
$0.39
Marknadsvärde
$13.79M
Förändring (1 dag)
-13.53%
Förändring (1 år)
-68.80%
Land
IL
Handel NeuroSense Therapeutics Ltd. (NRSN)

Kategori

Aktiekurshistorik för NeuroSense Therapeutics Ltd. (NRSN)
Högsta slutkurs: $0.47 den 2026-08-01

Lägsta slutkurs: $3.04 den 2021-12-01
Aktiekurshistorik för NeuroSense Therapeutics Ltd. från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE